Back
BridgeBio Pharma Stock Predictions
Sponsored
BBIO
Sponsored
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!
Buy
59
BBIO
BridgeBio Pharma
Last Price:
26.16
Seasonality Move:
14.81%
7 Day Trial
ALL ACCESS PASS
$
7
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!BridgeBio Pharma Stock Forecast
- Over the next 52 weeks, BridgeBio Pharma has on average historically risen by 33.2% based on the past 5 years of stock performance.
- BridgeBio Pharma has risen higher in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
-
Is BridgeBio Pharma Stock Undervalued?
The current BridgeBio Pharma [BBIO] share price is $25.52. The Score for BBIO is 59, which is 18% above its historic median score of 50, and infers lower risk than normal. - BBIO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will BridgeBio Pharma Stock Go Up Next Year?
- Over the next 52 weeks, BridgeBio Pharma has on average historically risen by 33.2% based on the past 5 years of stock performance.
BridgeBio Pharma Stock Rating
Buy
59
BridgeBio Pharma (BBIO)
is a Buy
Is BridgeBio Pharma overpriced?
- BridgeBio Pharma has risen higher in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
BridgeBio Pharma Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
bridgebio.com
52-Week Data
52-Week High:
44.32
52-Week Low:
21.62
Prediction Charts
Market Cap:
4.8B
Price in USD:
25.52
Volume:
1.12M
Beta:
1.07
Technical Analysis
SMA50:
25.93
SMA100:
25.90
SMA200:
28.01
52-Wk Change:
-11.48%
Stock Predictions
-
Is BridgeBio Pharma stock public?
Yes, BridgeBio Pharma is a publicly traded company. -
What is the BridgeBio Pharma stock quote today?
The BridgeBio Pharma stock price is 25.52 USD today. -
How to buy BridgeBio Pharma stock online?
You can buy BridgeBio Pharma shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Oct-16 | 25.62 | 26.34 | 26.78 | 25.62 |
Oct-18 | 26.21 | 26.02 | 26.66 | 25.89 |
Oct-21 | 25.71 | 25.16 | 26.10 | 25.02 |
Oct-22 | 25.02 | 24.94 | 25.21 | 24.76 |
Oct-23 | 24.93 | 24.45 | 25.19 | 24.20 |
Oct-24 | 24.56 | 24.17 | 24.81 | 24.12 |
Oct-25 | 24.17 | 23.84 | 24.90 | 23.76 |
Oct-28 | 24.07 | 24.44 | 24.85 | 23.92 |
Oct-29 | 24.17 | 24.50 | 24.68 | 24.12 |
Oct-30 | 24.23 | 23.81 | 24.68 | 23.78 |
Oct-31 | 23.80 | 23.41 | 24.53 | 23.39 |
Nov-1 | 23.51 | 25.48 | 25.64 | 23.35 |
Nov-4 | 25.00 | 25.19 | 25.81 | 24.39 |
Nov-5 | 25.01 | 25.52 | 25.55 | 24.46 |
BridgeBio Pharma Earnings
BridgeBio Pharma Earnings Report: Per Share BridgeBio Pharma Earnings Q1 Q2 Q3 and Q4 last year and next year.
BridgeBio Pharma Forecast Revenue Growth
BridgeBio Pharma Stock Analysis: Historical quarterly revenues per share for BridgeBio Pharma and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.24 per share, and a decrease next year of $1.05 per share.
* BridgeBio Pharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.